Atlas Trials

Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma

Clinical trial NCT04517214 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04517214
Sponsor
Fudan University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2020-11-01
Primary completion
2025-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.